| Typicality: | 0.446 |
| Saliency: | 0.460 |
| in about half of people | 9 | location |
| exactly how long | 4 | other |
| in clinical trials | 4 | location |
| vaccine → prevent → shingle | 60 |
| vaccine → help prevent → shingle | 16 |
| vaccine → protect against → shingle | 12 |
| negative | neutral | positive |
| 0.156 | 0.571 | 0.273 |
| Raw frequency | 88 |
| Normalized frequency | 0.460 |
| Modifier score | 0.500 |
| Perplexity | 27.149 |